Search results for "carrier peptide"

showing 1 items of 1 documents

Increased carrier peptide stability through ph adjustment improves insulin and pth(1-34) delivery in vitro and in vivo rather than by enforced carrie…

2020

Oral delivery of therapeutic peptides is hampered by their large molecular size and labile nature, thus limiting their permeation across the intestinal epithelium. Promising approaches to overcome the latter include co-administration with carrier peptides. In this study, the cell-penetrating peptide penetratin was employed to investigate effects of co-administration with insulin and the pharmacologically active part of parathyroid hormone (PTH(1-34)) at pH 5, 6.5, and 7.4 with respect to complexation, enzymatic stability, and transepithelial permeation of the therapeutic peptide in vitro and in vivo. Complex formation between insulin or PTH(1-34) and penetratin was pH-dependent. Micron-size…

insulinmedicine.medical_treatmentlcsh:RS1-441Pharmaceutical ScienceParathyroid hormonePeptide02 engineering and technologyArticlelcsh:Pharmacy and materia medica03 medical and health sciencespenetratinIn vivoCarrier peptide Cell-penetrating peptide Insulin Intestinal peptide delivery Penetratin PTH(1-34)Membrane activitymedicine030304 developmental biologychemistry.chemical_classification0303 health sciencesLiposomecarrier peptideChemistryInsulinPermeationintestinal peptide delivery021001 nanoscience & nanotechnologyBiophysicsCell-penetrating peptide0210 nano-technologyPTH(1-34)cell-penetrating peptide
researchProduct